Funding Rounds
Biofidelity

Biofidelity Seed (2019, $0M)

Biofidelity

Genomic technology developer to detect biomarkers for non-small cell lung cancer (NSCLC).

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Seed

Raised Amount: $0.94M

Raised Date: 2019-01-01